We’ve updated our website! Please click “Sign Up” today to create a new account so you can access your profile, manage prescriptions, and enjoy a seamless pharmacy experience.
New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.
Health News is provided as a service to Tremont Pharmacy site users by HealthDay. Tremont Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.